Antidepressant Paroxetine Exerts Developmental Neurotoxicity in an iPSC-Derived 3D Human Brain Model

Thumbnail Image
Date
2020
Authors
Zhong, Xiali
Harris, Georgina
Smirnova, Lena
Zufferey, Valentin
de Cássia da Silveira e Sá, Rita
Baldino Russo, Fabiele
Baleeiro Beltrao Braga, Patricia Cristina
Chesnut, Megan
Pamies, David
Editors
Contact
Journal ISSN
Electronic ISSN
ISBN
Bibliographical data
Publisher
Series
DOI (citable link)
ArXiv-ID
International patent number
Link to the license
EU project number
681002
Project
EUToxRisk21
Open Access publication
Collections
Restricted until
Title in another language
Research Projects
Organizational Units
Journal Issue
Publication type
Journal article
Publication status
Published
Published in
Frontiers in Cellular Neuroscience ; 14 (2020). - 25. - Frontiers Research Foundation. - eISSN 1662-5102
Abstract
Selective serotonin reuptake inhibitors (SSRIs) are frequently used to treat depression during pregnancy. Various concerns have been raised about the possible effects of these drugs on fetal development. Current developmental neurotoxicity (DNT) testing conducted in rodents is expensive, time-consuming, and does not necessarily represent human pathophysiology. A human, in vitro testing battery to cover key events of brain development, could potentially overcome these challenges. In this study, we assess the DNT of paroxetine—a widely used SSRI which has shown contradictory evidence regarding effects on human brain development using a versatile, organotypic human induced pluripotent stem cell (iPSC)-derived brain model (BrainSpheres). At therapeutic blood concentrations, which lie between 20 and 60 ng/ml, Paroxetine led to an 80% decrease in the expression of synaptic markers, a 60% decrease in neurite outgrowth and a 40–75% decrease in the overall oligodendrocyte cell population, compared to controls. These results were consistently shown in two different iPSC lines and indicate that relevant therapeutic concentrations of Paroxetine induce brain cell development abnormalities which could lead to adverse effects.
Summary in another language
Subject (DDC)
570 Biosciences, Biology
Keywords
paroxetine, SSRI, organoid, neurotoxicity, developmental neurotoxicity, 3D, iPSC
Conference
Review
undefined / . - undefined, undefined. - (undefined; undefined)
Cite This
ISO 690ZHONG, Xiali, Georgina HARRIS, Lena SMIRNOVA, Valentin ZUFFEREY, Rita DE CÁSSIA DA SILVEIRA E SÁ, Fabiele BALDINO RUSSO, Patricia Cristina BALEEIRO BELTRAO BRAGA, Megan CHESNUT, Thomas HARTUNG, David PAMIES, 2020. Antidepressant Paroxetine Exerts Developmental Neurotoxicity in an iPSC-Derived 3D Human Brain Model. In: Frontiers in Cellular Neuroscience. Frontiers Research Foundation. 14, 25. eISSN 1662-5102. Available under: doi: 10.3389/fncel.2020.00025
BibTex
@article{Zhong2020-02-21Antid-48821,
  year={2020},
  doi={10.3389/fncel.2020.00025},
  title={Antidepressant Paroxetine Exerts Developmental Neurotoxicity in an iPSC-Derived 3D Human Brain Model},
  volume={14},
  journal={Frontiers in Cellular Neuroscience},
  author={Zhong, Xiali and Harris, Georgina and Smirnova, Lena and Zufferey, Valentin and de Cássia da Silveira e Sá, Rita and Baldino Russo, Fabiele and Baleeiro Beltrao Braga, Patricia Cristina and Chesnut, Megan and Hartung, Thomas and Pamies, David},
  note={Article Number: 25}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/48821">
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/48821/1/Zhong_2-196deomaohfnu4.pdf"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-02-26T10:29:14Z</dc:date>
    <dc:contributor>Zufferey, Valentin</dc:contributor>
    <dc:creator>Zufferey, Valentin</dc:creator>
    <dc:creator>Baldino Russo, Fabiele</dc:creator>
    <dc:creator>Baleeiro Beltrao Braga, Patricia Cristina</dc:creator>
    <dc:contributor>Hartung, Thomas</dc:contributor>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Pamies, David</dc:creator>
    <dcterms:title>Antidepressant Paroxetine Exerts Developmental Neurotoxicity in an iPSC-Derived 3D Human Brain Model</dcterms:title>
    <dc:contributor>Harris, Georgina</dc:contributor>
    <dc:contributor>Baldino Russo, Fabiele</dc:contributor>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:contributor>Baleeiro Beltrao Braga, Patricia Cristina</dc:contributor>
    <dcterms:abstract xml:lang="eng">Selective serotonin reuptake inhibitors (SSRIs) are frequently used to treat depression during pregnancy. Various concerns have been raised about the possible effects of these drugs on fetal development. Current developmental neurotoxicity (DNT) testing conducted in rodents is expensive, time-consuming, and does not necessarily represent human pathophysiology. A human, in vitro testing battery to cover key events of brain development, could potentially overcome these challenges. In this study, we assess the DNT of paroxetine—a widely used SSRI which has shown contradictory evidence regarding effects on human brain development using a versatile, organotypic human induced pluripotent stem cell (iPSC)-derived brain model (BrainSpheres). At therapeutic blood concentrations, which lie between 20 and 60 ng/ml, Paroxetine led to an 80% decrease in the expression of synaptic markers, a 60% decrease in neurite outgrowth and a 40–75% decrease in the overall oligodendrocyte cell population, compared to controls. These results were consistently shown in two different iPSC lines and indicate that relevant therapeutic concentrations of Paroxetine induce brain cell development abnormalities which could lead to adverse effects.</dcterms:abstract>
    <dc:creator>Chesnut, Megan</dc:creator>
    <dc:contributor>Pamies, David</dc:contributor>
    <dcterms:issued>2020-02-21</dcterms:issued>
    <dc:contributor>Zhong, Xiali</dc:contributor>
    <dc:language>eng</dc:language>
    <dc:creator>de Cássia da Silveira e Sá, Rita</dc:creator>
    <dc:creator>Harris, Georgina</dc:creator>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-02-26T10:29:14Z</dcterms:available>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/48821/1/Zhong_2-196deomaohfnu4.pdf"/>
    <dc:contributor>Chesnut, Megan</dc:contributor>
    <dc:creator>Zhong, Xiali</dc:creator>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
    <dc:rights>Attribution 4.0 International</dc:rights>
    <dc:contributor>Smirnova, Lena</dc:contributor>
    <dc:creator>Hartung, Thomas</dc:creator>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Smirnova, Lena</dc:creator>
    <dc:contributor>de Cássia da Silveira e Sá, Rita</dc:contributor>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/48821"/>
  </rdf:Description>
</rdf:RDF>
Internal note
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Contact
URL of original publication
Test date of URL
Examination date of dissertation
Method of financing
Comment on publication
Alliance license
Corresponding Authors der Uni Konstanz vorhanden
International Co-Authors
Bibliography of Konstanz
Yes
Refereed
Yes